查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2006338

永續醫藥包裝市場：依包裝類型、材料、藥品類型、技術和最終用戶分類－2026-2032年全球市場預測

Sustainable Pharmaceutical Packaging Market by Packaging Type, Material, Drug Type, Technology, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，永續藥品包裝市場價值將達到 974.9 億美元，到 2026 年將成長至 1,086.4 億美元，到 2032 年將達到 2,352.8 億美元，複合年成長率為 13.41%。

主要市場統計數據
基準年 2025 974.9億美元
預計年份：2026年 1086.4億美元
預測年份 2032 2352.8億美元
複合年成長率 (%) 13.41%

簡要概述為什麼永續藥品包裝現在需要一種涵蓋安全、監管和環境優先事項的綜合營運方法。

藥品包裝處於病人安全、法規遵循、供應鏈韌性和環境管理的關鍵交匯點。隨著相關人員對產品完整性和永續性提出更高標準，包裝選擇不僅影響營運成本和物流，還影響品牌信譽和監管核准。本執行摘要概述了重塑整個藥品價值鏈包裝策略的結構性變革，揭示了材料創新、技術整合和政策趨勢如何融合，重新定義「實用型」包裝的含義。

永續材料、主動阻隔技術和數位可追溯性的融合如何重新定義藥品包裝的性能以及與供應商的關係。

在醫藥包裝領域，一系列變革正在發生，這主要歸因於多種因素的共同作用，包括對環境影響的監管力度加大、材料創新日新月異以及數位化溯源解決方案的普及。在整個價值鏈中，一次性容器正明顯地向兼具保護性、延長保存期限和可回收性的多功能系統轉變。諸如可生物分解聚合物和改良玻璃化合物等材料，不僅因其阻隔性能而受到評估，還因其對使用後處置途徑和碳排放的影響而受到關注。

本研究評估了近期關稅調整和貿易政策轉變對包裝產業供應鏈本地化、供應商多元化和材料認證計畫的影響。

2025年的累積關稅趨勢和貿易政策調整，已導致醫藥包裝材料和組件的成本結構和供應商決策發生變化。部分進口原料和組件關稅的提高，促使下游企業重新評估其總到岸成本、前置作業時間和庫存策略。為此，許多企業正在加快供應商多元化，優先選擇地理位置相近、垂直整合度高的合作夥伴，以降低貿易摩擦和運費波動帶來的風險。

透過對包裝類型、材料選擇、藥物配方、最終用戶需求和新興技術進行綜合細分分析，確定交叉點，從而指導策略投資。

詳細的細分觀點闡明了創新與風險的交集，突顯了研發和採購中的優先路徑。包裝形式包括安瓿、泡殼包裝、瓶子、軟袋和管瓶，每種形式又細分為玻璃和塑膠安瓿、紙質和多層泡殼、玻璃和塑膠瓶、鋁箔和紙質軟袋以及玻璃和塑膠管瓶子類型。這些區分至關重要，因為阻隔性能要求、滅菌相容性和回收途徑會因包裝形式而異。材料選擇包括生物分解性塑膠，例如PHA、PLA和澱粉聚合物；玻璃基材料，例如硼矽酸玻璃、燧石玻璃和鈉鈣玻璃；金屬，例如鋁和鋼；以及紙基基材，例如瓦楞紙板和牛皮紙。這些材料會影響產品在整個生命週期中的耐久性、滲透性、可回收性和環境影響之間的平衡。

影響美洲、歐洲、中東和非洲以及亞太市場包裝決策的區域優先事項和法規環境。

區域趨勢對包裝設計、採購和技術應用的策略選擇有顯著影響。在美洲，監管預期和對永續發展報告的強烈需求正促使製造商和合約包裝商投資於可回收包裝形式，並與本土材料供應商合作。這些市場對低溫運輸可靠性的重視以及大規模零售藥局通路的普及，也推動了穩健的二次包裝和可追溯性解決方案的發展。在歐洲、中東和非洲，政策催化劑和生產者延伸責任制（EPR）框架正在加速可重複使用和可回收材料的採用。然而，嚴格的管理體制要求提供經過驗證的安全性和合規性檢驗結果。在這些地區運作的製造商通常會優先考慮那些擁有明確的處置後處理路徑和生命週期文件的供應商。

市場領先的公司如何整合垂直整合、合作開發夥伴關係、可追溯性投資和檢驗服務，以便在包裝產業中獲得競爭優勢？

醫藥包裝生態系統中的主要企業正在採取多樣化但又互補的策略，以應對性能、永續性和法規方面的複雜挑戰。一些企業正在垂直整合其材料生產和加工能力，以確保供應的連續性並縮短新材料的認證週期。另一些企業則專注於與聚合物開發商和玻璃製造商建立戰略夥伴關係和共同開發契約，以加速採用檢驗的環保材料。投資建設中試生產線和模組化生產已成為降低資本風險和縮短檢驗時間的常用策略。

為採購、研發和監管回應團隊制定具體可行的步驟，以在包裝策略中平衡韌性、永續性和合規性。

產業領導企業應採取組合策略，在確保業務短期韌性的同時，兼顧向長期永續發展的轉型。首先，應優先考慮供應商多元化，透過認證地理位置相近地區的替代供應商，並為高風險材料建立雙重採購安排。同時，制定快速認證藍圖，以減少轉型過程中的摩擦。其次，投資於有針對性的材料替代試點項目，在實際應用和無菌條件下評估可生物分解聚合物和先進玻璃配方的穩定性，並利用跨職能團隊加速技術檢驗，證明其符合監管要求。

我們透過透明的混合方法，結合專家訪談、供應鏈檢驗、技術評估和案例研究。

本研究採用混合方法，將質性專家見解與結構化的供應鏈分析和技術評估結合。初步研究包括對高級包裝工程師、法規遵循專家、採購經理和供應商技術經理進行深入訪談，並輔以現場考察和線上研討會，以檢驗材料性能聲明和合格流程。後續研究則對法規指南、技術標準、生命週期評估 (LCA) 文獻以及已發布的材料安全和合規資料進行系統性回顧，以支持初步研究的發現並建立風險框架。

這清楚地表明了為什麼跨部門協作和分階段實施對於實現包裝產品安全和永續性目標至關重要。

永續的藥品包裝不再只是一個理想目標，它已成為品質、合規性和企業社會責任三者交匯的關鍵營運要素。材料創新、技術驅動的可追溯性以及不斷變化的貿易動態正在重塑行業格局，所有這些因素共同要求更靈活的採購方式、更強大的供應商夥伴關係以及更嚴格的檢驗方法。為了取得成功，企業必須以整體視角看待包裝決策，並將其視為跨職能投資，因為它會影響產品安全、病患療效和環境績效。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章永續藥品包裝市場：依包裝類型分類

  • 安瓿
    • 玻璃安瓿
    • 塑膠安瓿
  • 泡殼包裝
    • 紙包裝
    • PVC鋁箔包裝
    • PVDC電池組
  • 瓶子
    • 玻璃瓶
    • 塑膠瓶
  • 小袋
    • 鋁箔袋
    • 紙袋
  • 管瓶
    • 玻璃管瓶
    • 塑膠管瓶

第9章：永續醫藥包裝市場：依材料分類

  • 生物分解性塑膠
    • PHA
    • PLA
    • 澱粉基聚合物
  • 玻璃
    • 硼矽酸玻璃
    • 燧石
    • 鈉石灰
  • 金屬
    • 鋁
    • 鋼
  • 紙張和紙板
    • 紙板
    • 牛皮紙

第10章：永續藥品包裝市場：依藥品類型分類

  • 液體
    • 解決方案
    • 懸浮液
  • 半固態製劑
    • 奶油
    • 凝膠
    • 軟膏
  • 固態劑型
    • 膠囊
    • 藥片

第11章：永續醫藥包裝市場：依科技分類

  • 活性包裝
    • 乙烯清除劑
    • 氧氣吸收器
  • 智慧包裝
    • NFC
    • QR碼
    • RFID
  • 調氣包裝
    • 地圖容器
    • MAP 薄膜
  • 真空包裝
    • 蓋膜
    • 真空袋

第12章永續醫藥包裝市場：依最終用戶分類

  • 診所
  • 醫院
  • 網路藥房
  • 研究機構
  • 零售藥房

第13章永續醫藥包裝市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章永續醫藥包裝市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章永續藥品包裝市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國：永續藥品包裝市場

第17章 中國：永續醫藥包裝市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Adelphi Healthcare Packaging
  • Amcor plc
  • AptarGroup Inc.
  • Berry Global Group Inc.
  • Bormioli Pharma SpA
  • CCL Industries Inc.
  • Comar LLC
  • Constantia Flexibles Group GmbH
  • Datwyler Holding Inc.
  • DWK Life Sciences GmbH
  • Gerresheimer AG
  • Huhtamaki Oyj
  • Nipro Corporation
  • O.Berk Company LLC
  • Pacific Vial Manufacturing Inc.
  • Schott AG
  • SGD Pharma
  • Silgan Holdings Inc.
  • Stevanato Group SpA
  • UDG Healthcare plc
  • Vetter Pharma International GmbH
  • Weener Plastics Group
  • West Pharmaceutical Services Inc.
Product Code: MRR-67236922860E

The Sustainable Pharmaceutical Packaging Market was valued at USD 97.49 billion in 2025 and is projected to grow to USD 108.64 billion in 2026, with a CAGR of 13.41%, reaching USD 235.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 97.49 billion
Estimated Year [2026] USD 108.64 billion
Forecast Year [2032] USD 235.28 billion
CAGR (%) 13.41%

A concise orientation to why sustainable pharmaceutical packaging now demands integrated operational approaches across safety, regulation, and environmental priorities

Pharmaceutical packaging sits at the intersection of patient safety, regulatory compliance, supply chain resilience, and environmental stewardship. As stakeholders demand higher standards for product integrity and sustainability, packaging choices increasingly determine not only operational cost and logistics, but also brand trust and regulatory acceptance. This executive summary distills the structural shifts reshaping packaging strategies across the pharmaceutical value chain, highlighting how material innovation, technology integration, and policy dynamics coalesce to redefine what "fit for purpose" packaging entails.

The analysis that follows frames both immediate and strategic considerations for manufacturers, contract packagers, material suppliers, and healthcare providers. It emphasizes pragmatic pathways to balance product protection with environmental responsibility, showing how firms can reduce systemic risk without compromising compliance. By synthesizing technological trajectories, supply chain pressures, and regional policy contexts, the summary equips leaders with an actionable perspective to align short-term operational choices with longer-term sustainability commitments. Readers should expect clear, implementable insights intended to guide sourcing, R&D prioritization, and cross-functional coordination.

How convergence of sustainable materials, active barrier technologies, and digital traceability is redefining pharmaceutical packaging performance and supplier relationships

The pharmaceutical packaging landscape is undergoing a series of transformative shifts driven by converging forces: heightened regulatory scrutiny for environmental impact, rapid material innovation, and the proliferation of digital traceability solutions. Across the value chain, there is a tangible move from single-purpose containers toward multifunctional systems that combine protection, extended shelf life, and circularity. Materials such as biodegradable polymers and enhanced glass formulations are being evaluated not only for barrier performance but also for end-of-life pathways and carbon implications.

Parallel to material change, packaging technologies that actively manage product micro-environments and provide real-time information are gaining traction. Active packaging components like oxygen and ethylene scavengers and intelligent layers enabled by NFC and RFID are being integrated to improve stability and reduce waste. Moreover, manufacturers increasingly favor modular design and compatibility with sterilization methods to streamline manufacturing and logistics. These shifts are prompting a re-evaluation of supplier relationships, quality assurance protocols, and capital allocation decisions, as firms balance the imperative for sustainability with the uncompromising requirements of patient safety and regulatory compliance.

Assessing how recent tariff adjustments and trade policy shifts have catalyzed supply chain localization, supplier diversification, and material qualification programs in packaging

Cumulative tariff activity and trade policy adjustments in 2025 have altered cost dynamics and supplier decisions for pharmaceutical packaging materials and components. Increased levies on certain imported raw materials and components have encouraged downstream players to reassess total landed cost, lead times, and inventory strategies. In response, many organizations have accelerated supplier diversification efforts, prioritizing geographically proximate and vertically integrated partners to mitigate exposure to trade friction and freight volatility.

The tariff-driven rebalancing has also amplified interest in material substitution where domestic availability is strong; for example, sourcing alternatives to certain coated films and metal components has become more attractive when tariff differentials erode cost advantages of long-distance suppliers. At the same time, regulatory compliance considerations and the need for validated material equivalence mean that transitions cannot be purely cost-driven. Firms have increased investment in qualification protocols and in collaborative trials with material suppliers to ensure that changes in sourcing do not compromise drug stability or packaging integrity. Ultimately, trade measures in 2025 served as a catalyst for greater supply chain localization, stronger supplier partnerships, and more disciplined scenario planning across procurement and regulatory teams.

An integrated segmentation analysis revealing where packaging types, material choices, drug formulations, end-user needs, and emerging technologies intersect to guide strategic investment

A granular segmentation lens clarifies where innovation and risk converge and illuminates priority pathways for development and procurement. Packaging types span ampoules, blister packs, bottles, pouches, and vials, each with subtypes such as glass versus plastic ampoules, paper and multi-layer blister constructions, glass and plastic bottles, foil and paper pouches, and glass and plastic vials; these distinctions matter because barrier needs, sterilization compatibility, and recycling routes vary significantly across formats. Material choices encompass biodegradable plastics-including PHA, PLA, and starch-based polymers-glass variants like borosilicate, flint, and soda lime, metals such as aluminum and steel, and paper-based substrates including corrugated board and kraft paper; these materials drive trade-offs between durability, permeability, recyclability, and life-cycle footprint.

Drug type segmentation-liquid dosage formulations (solutions and suspensions), semi-solid forms (creams, gels, ointments), and solid dosages (capsules and tablets)-creates distinct stability demands that influence container selection, barrier specification, and secondary packaging. End users range from clinics and hospitals to online and retail pharmacies, and research laboratories, each imposing unique handling, storage, and patient-facing requirements that shape packaging ergonomics and labeling. Technology-driven categories include active packaging with ethylene and oxygen scavengers, intelligent solutions leveraging NFC, QR, and RFID for authentication and data capture, modified atmosphere options via MAP containers and films, and vacuum systems employing lidding films and vacuum pouches; selecting among these technologies requires aligning functional performance with cost, regulatory considerations, and sustainability objectives. By examining these segments together, firms can prioritize innovation investments where material and format transitions yield the greatest impact on performance, compliance, and environmental outcomes.

Regional priorities and regulatory contexts that shape packaging decisions across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics substantially influence strategic choices in packaging design, sourcing, and technology adoption. In the Americas, regulatory expectations and strong demand for sustainability reporting have prompted manufacturers and contract packagers to invest in recyclable formats and to pursue partnerships with domestic material suppliers; the market's emphasis on cold-chain reliability and large retail pharmacy channels also favors robust secondary packaging and traceability solutions. In Europe, Middle East & Africa, policy drivers and extended producer responsibility frameworks are accelerating the adoption of reusable and recyclable materials, while stringent regulatory regimes insist on validated safety and compatibility testing; manufacturers operating in this region often prioritize materials with clear end-of-life pathways and suppliers that can provide lifecycle documentation.

Across Asia-Pacific, rapid growth in local pharmaceutical manufacturing and a diverse range of end-user infrastructures have led to a dual focus on cost-effective materials and scalable technology solutions. In several markets, novel biodegradable polymers are being trialed at scale, and there is brisk adoption of intelligent labeling to support anti-counterfeiting and remote patient engagement. Regional supply chains in Asia-Pacific also play a pivotal role in global sourcing, making supplier qualification and quality assurance critical for multinational firms that rely on components produced there. Together, these regional nuances require multinational packaging strategies that balance centralized standards with localized execution and supplier ecosystems.

How market leaders are aligning vertical integration, co-development partnerships, traceability investments, and validation services to gain competitive advantage in packaging

Leading companies in the pharmaceutical packaging ecosystem are pursuing distinct but complementary strategies to navigate performance, sustainability, and regulatory complexity. Some players are vertically integrating material production and converting capabilities to secure supply continuity and to reduce qualification cycles for new materials. Others focus on strategic partnerships and co-development agreements with polymer innovators and glass manufacturers to accelerate the introduction of validated, low-impact materials. Investment in pilot lines and modular manufacturing has become a common tactic to shorten time-to-validation while limiting capital exposure.

Across the competitive landscape, firms are differentiating through certification and traceability credentials, leveraging technologies like RFID and cryptographic QR implementations to meet anti-counterfeiting and provenance demands. Another common thread is the emphasis on technical service: suppliers offering comprehensive validation support, stability study collaboration, and regulatory dossier assistance are gaining preference among pharmaceutical companies. Mergers and targeted acquisitions are also shaping the sector, enabling buyers to expand technology portfolios and regional footprints. Collectively, these company-level tactics reflect a shift from transactional supply models to partnership-focused engagements that align commercial terms with long-term technical collaboration and sustainability outcomes.

Targeted, actionable measures for procurement, R&D, and regulatory teams to balance resilience, sustainability, and compliance in packaging strategies

Industry leaders should adopt a portfolio approach that balances immediate operational resilience with longer-term sustainability transitions. First, prioritize supplier diversification by qualifying alternative vendors across regionally proximate geographies and by establishing dual-sourcing arrangements for high-risk materials; simultaneously develop accelerated qualification roadmaps that reduce switching friction. Next, invest in targeted material substitution pilots that evaluate biodegradable polymers and advanced glass formulations under real-world stability and sterilization conditions, using cross-functional teams to expedite technical validation and to document regulatory equivalence.

Leaders should also scale intelligent packaging pilots that deliver measurable returns, such as reduced counterfeiting risk, improved cold-chain monitoring, or lower product loss, then expand those solutions where ROI is demonstrated. Implement robust end-of-life strategies by collaborating with recycling value chains and by specifying mono-material constructions when possible to enhance recyclability. To manage trade and tariff exposure, enact scenario-based procurement plans and maintain buffer inventories for critical components while negotiating flexible commercial terms. Finally, embed clear sustainability metrics into supplier scorecards and purchasing decisions, align R&D roadmaps with regulatory trajectories, and maintain active dialogue with regulators and industry consortia to shape practical, harmonized standards.

A transparent mixed-methods research design combining expert interviews, supply chain validation, technical assessments, and case studies to ensure practical, reproducible insights

This research employs a mixed-methods approach that synthesizes qualitative expert insight with structured supply chain analysis and technical assessment. Primary research consisted of in-depth interviews with senior packaging engineers, regulatory affairs specialists, procurement leads, and supplier technical managers, complemented by site visits and virtual workshops to validate material performance claims and qualification workflows. Secondary research included a systematic review of regulatory guidance, technical standards, lifecycle assessment literature, and published material safety and compatibility data to corroborate primary findings and to inform risk frameworks.

Data triangulation was used throughout to reconcile differing perspectives and to ensure that technical recommendations reflect real-world constraints. Case studies were developed to illustrate successful transitions in materials and technologies, including detailed accounts of validation pathways and commercial arrangements. Limitations include variability in regional regulatory timelines and emerging data on novel biodegradable polymers; where evidence remains nascent, recommendations emphasize pilot testing and staged qualification. The methodology prioritizes reproducibility and transparency, and documentation is provided so practitioners can adapt evaluation sequences to their internal governance and risk tolerance.

A decisive synthesis of why cross-functional alignment and phased implementation are essential to realize both product safety and sustainability objectives in packaging

Sustainable pharmaceutical packaging is no longer an aspirational goal; it is an operational imperative that intersects quality, compliance, and corporate responsibility. The landscape is being reshaped by material innovations, technology-enabled traceability, and shifting trade dynamics that together demand more agile sourcing, stronger supplier partnerships, and rigorous validation practices. Success requires organizations to think holistically about packaging decisions, treating them as cross-functional investments that affect product safety, patient outcomes, and environmental performance.

By integrating the segmentation insights, regional nuances, and company tactics described above, decision-makers can construct phased strategies that mitigate near-term risks while building capacity for long-term transformation. Incremental pilots, robust supplier qualification, and targeted technology deployment will allow firms to both satisfy regulatory requirements and achieve measurable sustainability improvements. The most resilient companies will be those that align commercial incentives with technical collaboration and that institutionalize continuous learning between procurement, R&D, and regulatory teams.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sustainable Pharmaceutical Packaging Market, by Packaging Type

  • 8.1. Ampoules
    • 8.1.1. Glass Ampoules
    • 8.1.2. Plastic Ampoules
  • 8.2. Blister Packs
    • 8.2.1. Paper Packs
    • 8.2.2. Pvc Aluminum Packs
    • 8.2.3. Pvdc Packs
  • 8.3. Bottles
    • 8.3.1. Glass Bottles
    • 8.3.2. Plastic Bottles
  • 8.4. Pouches
    • 8.4.1. Foil Pouches
    • 8.4.2. Paper Pouches
  • 8.5. Vials
    • 8.5.1. Glass Vials
    • 8.5.2. Plastic Vials

9. Sustainable Pharmaceutical Packaging Market, by Material

  • 9.1. Biodegradable Plastics
    • 9.1.1. Pha
    • 9.1.2. Pla
    • 9.1.3. Starch Based Polymers
  • 9.2. Glass
    • 9.2.1. Borosilicate
    • 9.2.2. Flint
    • 9.2.3. Soda Lime
  • 9.3. Metal
    • 9.3.1. Aluminum
    • 9.3.2. Steel
  • 9.4. Paper Cardboard
    • 9.4.1. Corrugated Board
    • 9.4.2. Kraft Paper

10. Sustainable Pharmaceutical Packaging Market, by Drug Type

  • 10.1. Liquid Dosage
    • 10.1.1. Solutions
    • 10.1.2. Suspensions
  • 10.2. Semi Solid Dosage
    • 10.2.1. Creams
    • 10.2.2. Gels
    • 10.2.3. Ointments
  • 10.3. Solid Dosage
    • 10.3.1. Capsules
    • 10.3.2. Tablets

11. Sustainable Pharmaceutical Packaging Market, by Technology

  • 11.1. Active Packaging
    • 11.1.1. Ethylene Scavengers
    • 11.1.2. Oxygen Scavengers
  • 11.2. Intelligent Packaging
    • 11.2.1. Nfc
    • 11.2.2. Qr Code
    • 11.2.3. Rfid
  • 11.3. Modified Atmosphere Packaging
    • 11.3.1. Map Containers
    • 11.3.2. Map Films
  • 11.4. Vacuum Packaging
    • 11.4.1. Lidding Films
    • 11.4.2. Vacuum Pouches

12. Sustainable Pharmaceutical Packaging Market, by End User

  • 12.1. Clinics
  • 12.2. Hospitals
  • 12.3. Online Pharmacies
  • 12.4. Research Laboratories
  • 12.5. Retail Pharmacies

13. Sustainable Pharmaceutical Packaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Sustainable Pharmaceutical Packaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Sustainable Pharmaceutical Packaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Sustainable Pharmaceutical Packaging Market

17. China Sustainable Pharmaceutical Packaging Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Adelphi Healthcare Packaging
  • 18.6. Amcor plc
  • 18.7. AptarGroup Inc.
  • 18.8. Berry Global Group Inc.
  • 18.9. Bormioli Pharma S.p.A.
  • 18.10. CCL Industries Inc.
  • 18.11. Comar LLC
  • 18.12. Constantia Flexibles Group GmbH
  • 18.13. Datwyler Holding Inc.
  • 18.14. DWK Life Sciences GmbH
  • 18.15. Gerresheimer AG
  • 18.16. Huhtamaki Oyj
  • 18.17. Nipro Corporation
  • 18.18. O.Berk Company LLC
  • 18.19. Pacific Vial Manufacturing Inc.
  • 18.20. Schott AG
  • 18.21. SGD Pharma
  • 18.22. Silgan Holdings Inc.
  • 18.23. Stevanato Group S.p.A.
  • 18.24. UDG Healthcare plc
  • 18.25. Vetter Pharma International GmbH
  • 18.26. Weener Plastics Group
  • 18.27. West Pharmaceutical Services Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ACTIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ACTIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ETHYLENE SCAVENGERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ETHYLENE SCAVENGERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ETHYLENE SCAVENGERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OXYGEN SCAVENGERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OXYGEN SCAVENGERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OXYGEN SCAVENGERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY INTELLIGENT PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY INTELLIGENT PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY INTELLIGENT PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY INTELLIGENT PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY NFC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY NFC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY NFC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY QR CODE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY QR CODE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY QR CODE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY RFID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY RFID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY RFID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MODIFIED ATMOSPHERE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MODIFIED ATMOSPHERE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MODIFIED ATMOSPHERE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MODIFIED ATMOSPHERE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MAP CONTAINERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MAP CONTAINERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MAP CONTAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MAP FILMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MAP FILMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MAP FILMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VACUUM PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VACUUM PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VACUUM PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VACUUM PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIDDING FILMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIDDING FILMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIDDING FILMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VACUUM POUCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VACUUM POUCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VACUUM POUCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, 2018-2032 (USD MILLION)
  • TABLE 205. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 206. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, 2018-2032 (USD MILLION)
  • TABLE 207. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 208. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 209. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, 2018-2032 (USD MILLION)
  • TABLE 210. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 212. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 213. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 214. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 216. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY INTELLIGENT PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 217. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MODIFIED ATMOSPHERE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 218. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VACUUM PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 219. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, 2018-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 228. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, 2018-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 230. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, 2018-2032 (USD MILLION)
  • TABLE 232. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 234. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 236. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 238. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY INTELLIGENT PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MODIFIED ATMOSPHERE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VACUUM PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, 2018-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 252. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, 2018-2032 (USD MILLION)
  • TABLE 254. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 256. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 258. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 260. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY INTELLIGENT PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MODIFIED ATMOSPHERE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 262. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VACUUM PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICA